INOGEN INC
Inogen Inc (INGN) designs and sells portable oxygen concentrators used by people with chronic respiratory conditions such as COPD. Its products are aimed at providing mobility and home-based oxygen therapy through lighter, battery-powered devices sold via direct channels, home medical equipment providers and international distributors. Demand is supported by an ageing population and a shift from bulky oxygen tanks to portable solutions, but sales are sensitive to reimbursement policies, clinical adoption cycles and supply-chain dynamics. As a relatively small-cap medical-device company (market cap ~ $230m), Inogen may offer growth potential alongside greater volatility and execution risk than larger peers. Key factors to watch include product innovation, international expansion, service and accessory revenue, and regulatory oversight. This summary is general educational information only and not personal financial advice; values can fall as well as rise, so investors should consider their own risk tolerance and seek professional advice if needed.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Inogen's stock, believing it has potential to reach a higher price.
Financial Health
Inogen is successfully generating solid revenue and cash flow, indicating good financial performance.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
Abbott
Abbott Laboratories is a global healthcare company that develops and markets a broad range of health care products, including medical devices, diagnostics, nutritionals, and branded generic pharmaceuticals.
AGILENT TECHNOLOGIES INC
Agilent Technologies, Inc. specializes in life sciences, diagnostics and applied markets, providing application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. Its segments include Life Sciences and Diagnostics Markets, Agilent CrossLab and Applied Markets. The Life Sciences and Diagnostics Markets segment provides contract development and manufacturing services for pharmaceutical customers as well as solutions that include reagents, instruments, software and consumables which enable customers in the clinical and life sciences research areas to interrogate samples at the cellular and molecular level. The Agilent CrossLab segment spans the entire lab with its services and consumables portfolio in addition to software and laboratory automation solutions, which are designed to improve customer outcomes and represent a range of offerings designed to serve customer needs across end-markets and applications.
ALIGN TECHNOLOGY INC
Align Technology is a medical device company that designs, manufactures and markets a range of dental and orthodontic products.
Baskets Featuring INGN
At-Home Healthcare Stocks Explained | FDA Approval
The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug simplifies treatment and reduces the need for hospital visits. This development highlights a broader trend toward at-home care, creating potential investment opportunities in companies that provide related medical devices and healthcare services.
Published: August 30, 2025
Explore BasketWhy You’ll Want to Watch This Stock
Mobility trend
Portable oxygen devices support patient mobility and home care, a sector worth watching as ageing populations increase demand — though reimbursement shifts can affect uptake.
International expansion
Overseas markets and distributor networks offer growth opportunities, but local regulations and market access can create variability in outcomes.
Product innovation
Battery life, noise reduction and service offerings matter for competitiveness; technical advances may boost appeal, yet competition and execution risk remain.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
